# Leadership, Planning an Evaluation

> **NIH NIH P30** · INDIANA UNIVERSITY INDIANAPOLIS · 2024 · $481,430

## Abstract

ABSTRACT, Leadership, Planning, and Evaluation
The Indiana University Simon Comprehensive Cancer Center (IUSCCC) has established an effective process
for Leadership, Planning, and Evaluation that receives input from its senior leaders, Research Program leaders,
and members as well as internal and external advisory committees. The current grant period has seen
recruitment of a new Director (Dr. Kelvin Lee) and expansion of the senior leadership team to oversee new
IUSCCC-wide initiatives through creation of Associate Director positions in Data Science (Dr. Kun Huang),
Diversity, Equity, and Inclusion (Dr. Antwione Haywood), and System Integration (Ms. Katie McGill, IU Health).
These changes have enhanced formal strategic integration and coordination among IUSCCC, the IU School of
Medicine (IUSM), and the IU Health system. Based on internal and external input, the IUSCCC leadership has
developed and implemented its Strategic Plan and has continuously assessed the plan's impact on the four
Research Programs and multiple Shared Resources in advancing the IUSCCC mission to serve the population
of Indiana and beyond. The Strategic Plan has evolved from 2018 through its most recent update in 2023 to a
framework that contains three major components: Foundational Organizational Capabilities; Integrating Efforts
(education, data science, community outreach and engagement); and Cross-Cutting Scientific Themes
(mechanism-based medicine, bench↔bedside↔main street translational research, population health, social
responsibility and policy). Following this Strategic Plan, the senior leadership has implemented a number of
actions over the current grant period. These include appointment of new leadership in the four Research
Programs: Cancer Prevention and Control (Dr. Katzenellenbogen), Experimental and Developmental
Therapeutics (Drs. Opyrchal and Pollok), Tumor Microenvironment and Metastasis (Dr. Fishel), and
Hematopoiesis and Hematologic Malignancies (Dr. Salman). Additionally, new transdisciplinary research
initiatives (e.g., the Brown Center for Immunotherapy), translational development platforms (e.g., the Cancer
Drug Discovery and Development Accelerator), and educational programs (e.g., the Translational Cancer
Biology PhD program) have been launched. There has also been significant expansion of the Office of
Community Outreach and Engagement and development of the Plan to Enhance Diversity (PED). These and
other initiatives drive IUSCCC's mission to impact research, patient care, and education both locally and globally.
To accomplish these, the Leadership, Planning, and Evaluation aims are to: 1) further increase the depth of
Team Science, both intra- and extramurally, geared towards reducing the burden of cancer, 2) amplify cancer
outreach and community engagement activities within our catchment area and beyond, 3) create a strong
planning process that aligns the tripartite mission of IUSCCC, IUSM, and the clinical enterprise through strategic
plannin...

## Key facts

- **NIH application ID:** 10934644
- **Project number:** 2P30CA082709-25
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** KELVIN P. LEE
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $481,430
- **Award type:** 2
- **Project period:** 1999-09-22 → 2029-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10934644

## Citation

> US National Institutes of Health, RePORTER application 10934644, Leadership, Planning an Evaluation (2P30CA082709-25). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10934644. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*